Skip to main content

Table 4 Comparison of clinical characters of non-vaccine serotypes and vaccine serotypes related definite pneumococcal pneumonia

From: The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia

  Coverage serotype p-value
Noc Yesd
N = 21 N = 37
Processing of pneumonia severity
 Pleural fluid aspiration 7 (33.33) 19 (51.35) 0.185a
 Chest catheter use 12 (57.14) 31 (83.78) 0.026a
 VATS 9 (42.86) 29 (78.38) 0.006a
 ICU admission 12 (57.14) 30 (81.08) 0.050a
 Days in ICU 6.9 ± 4.1 8.6 ± 11.9 0.635b
 O2 use 14 (66.67) 30 (81.08) 0.218a
 O2 use day >=7 days 8 (38.10) 16 (43.24) 0.702a
 Admission days >= 14 days 12 (57.14) 29 (78.38) 0.088a
 One of the above 16 (76.19) 37 (91.38) 0.004a
 Two of the above 14 (66.67) 36 (97.30) 0.002a
 Three of the above 14 (66.67) 34 (91.89) 0.027a
Blood tests
 Lowest Hb (g/ dl) 10.0 ± 1.8 9.2 ± 0.9 0.049b
 Highest WBC (x k/ cumm) 19.6 ± 9.2 24.1 ± 9.3 0.080b
 Highest Bandemia (%) 6.9 ± 9.1 11.6 ± 17.0 0.198b
 Highest Neutrophilis (x k/ cumm) 39.1 ± 31.6 55.6 ± 32.4 0.069b
 Highest Lymphocytes (x k/ cumm) 11.9 ± 14.1 18.4 ± 16.5 0.132b
 Highest Eosinophils (x k/ cumm) 0.9 ± 1.8 2.2 ± 2.4 0.038b
 Highest Platelets (x k/ cumm) 577.8 ± 228.9 663.4 ± 249.0 0.201b
 Highest CRP (mg/ dl) 23.7 ± 10.6 29.5 ± 9.8 0.038b
  1. Numbers in bold indicate statistical significance (p<0.05)
  2. Data are shown as N (%) for categorical variable and mean ± standard deviation for continuous variable; VATS, video-assisted thoracoscopic surgery; ICU, intensive care unit
  3. a Chi-square test
  4. b Student's t-test
  5. c all of the non-vaccine coverage serotypes are unknown serotypes
  6. d vaccine coverage serotype including 7 with serotype 3, one case with serotype 6, 27 with serotype 19A, 2 with serotype 19F